{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:20:01Z","timestamp":1779175201341,"version":"3.51.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"DOI":"10.1097\/qai.0b013e31804a85b0","type":"journal-article","created":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T08:03:49Z","timestamp":1177488229000},"page":"72-76","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence of and Risk Factors for Pubic Lipoma Development in HIV-Infected Persons"],"prefix":"10.1097","volume":"45","author":[{"given":"Giovanni","family":"Guaraldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Squillace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Roverato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"De Fazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"Vandelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Nardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Beghetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"De Paola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Palella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210131","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1097\/00002030-200111090-00004","article-title":"Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways.","volume":"15","author":"van der Valk","year":"2001","journal-title":"AIDS"},{"key":"R2-11-20210131","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/317477","article-title":"Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe dEpidemiologie Clinique du Syndrome dImmunodeficience Acquise en Aquitaine.","volume":"31","author":"Thiebaut","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R3-11-20210131","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","article-title":"Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study.","volume":"14","author":"Saint-Marc","year":"2000","journal-title":"AIDS"},{"key":"R4-11-20210131","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.","volume":"13","author":"Saint-Marc","year":"1999","journal-title":"AIDS"},{"key":"R5-11-20210131","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00126334-200011010-00014","article-title":"Lipoatrophy, fat accumulation, and mixed syndrome in protease inhibitor-naive HIV-infected patients.","volume":"25","author":"Polo","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-11-20210131","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1097\/00002030-200010200-00025","article-title":"Lipodystrophy following antiretroviral therapy of primary HIV infection.","volume":"14","author":"Miller","year":"2000","journal-title":"AIDS"},{"key":"R7-11-20210131","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1468-1293.2003.00159.x","article-title":"HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.","volume":"4","author":"Miller","year":"2003","journal-title":"HIV Med"},{"key":"R8-11-20210131","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.","volume":"357","author":"Martinez","year":"2001","journal-title":"Lancet"},{"key":"R9-11-20210131","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00126334-200301010-00007","article-title":"Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients.","volume":"32","author":"Lichtenstein","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-11-20210131","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population.","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"R11-11-20210131","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-200212060-00010","article-title":"Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial.","volume":"16","author":"Joly","year":"2002","journal-title":"AIDS"},{"key":"R12-11-20210131","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/ajcn\/78.4.790","article-title":"High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition.","volume":"78","author":"Hendricks","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"R13-11-20210131","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1097\/00002030-200009080-00008","article-title":"Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy.","volume":"14","author":"Hatano","year":"2000","journal-title":"AIDS"},{"key":"R14-11-20210131","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00002030-200101260-00024","article-title":"Incidence of clinical lipodystrophy in HIV-infected patients treated during primary infection.","volume":"15","author":"Goujard","year":"2001","journal-title":"AIDS"},{"key":"R15-11-20210131","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","article-title":"Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy.","volume":"13","author":"Gervasoni","year":"1999","journal-title":"AIDS"},{"key":"R16-11-20210131","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1001\/archinte.162.22.2621","article-title":"Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study.","volume":"162","author":"Galli","year":"2002","journal-title":"Arch Intern Med"},{"key":"R17-11-20210131","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1468-1293.2001.00073.x","article-title":"The prevalence of lipodystrophy in an ambulant HIV-infected population: it all depends on the definition.","volume":"2","author":"Carter","year":"2001","journal-title":"HIV Med"},{"key":"R18-11-20210131","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"R19-11-20210131","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00042560-200107010-00004","article-title":"Stavudine versus zidovudine and the development of lipodystrophy.","volume":"27","author":"Bogner","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R20-11-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00042560-200201010-00003","article-title":"Body habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors.","volume":"29","author":"Galli","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R21-11-20210131","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","article-title":"An objective case definition of lipodystrophy in HIV-infected adults: a case-control study.","volume":"361","author":"Carr","year":"2003","journal-title":"Lancet"},{"key":"R22-11-20210131","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00126334-200210010-00019","article-title":"HIV-associated lipodystrophy syndrome: LioN-HAART cohort: (lipodystrophy in patients on nucleoside-based HAART). Highly active antiretroviral therapy.","volume":"31","author":"Lauenroth-Mai","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-11-20210131","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"R24-11-20210131","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00042560-200004010-00012","article-title":"Lipodystrophy: results of a data evaluation of patients receiving nelfinavir-containing combination therapy.","volume":"23","author":"Lewis","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-11-20210131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1310\/EYWJ-8B5K-X7VQ-9CPE","article-title":"Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy.","volume":"7","author":"Guaraldi","year":"2006","journal-title":"HIV Clin Trials"},{"key":"R27-11-20210131","first-page":"347","article-title":"Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy.","volume":"8","author":"Galli","year":"2003","journal-title":"Antivir Ther"},{"key":"R28-11-20210131","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.qai.0000159323.59250.83","article-title":"Increased cardiovascular disease risk indices in HIV-infected women.","volume":"39","author":"Dolan","year":"2005","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200705010-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:19:05Z","timestamp":1618039145000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200705010-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31804a85b0","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5,1]]}}}